Aker BioMarine ASA (OSL:AKBM) Additional Paid-In Capital : kr5,240 Mil(As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA Additional Paid-In Capital?

Aker BioMarine ASA's quarterly additional paid-in capital declined from Sep. 2023 (kr5,686 Mil) to Dec. 2023 (kr5,593 Mil) but then stayed the same from Dec. 2023 (kr5,593 Mil) to Mar. 2024 (kr5,240 Mil).

Aker BioMarine ASA's annual additional paid-in capital increased from Dec. 2021 (kr4,759 Mil) to Dec. 2022 (kr5,237 Mil) and increased from Dec. 2022 (kr5,237 Mil) to Dec. 2023 (kr5,593 Mil).

Aker BioMarine ASA Additional Paid-In Capital Historical Data

The historical data trend for Aker BioMarine ASA's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Additional Paid-In Capital Chart

Aker BioMarine ASA Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

2,823.10

4,613.86

4,759.09

5,237.44

5,593.29

Aker BioMarine ASA Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															5,583.17	5,724.25	5,686.24	5,593.29	5,240.26

Aker BioMarine ASA Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Aker BioMarine ASA Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Aker BioMarine ASA (OSL:AKBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

1PG:Germany

Address

Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327

Website

https://www.akerbiomarine.com

Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines